HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Antidepressants Linked to Implant Failure

By HospiMedica International staff writers
Posted on 21 Mar 2016
Print article
A new study finds that antidepressants, commonly used to treat anxiety, pain, and other disorders, may play a role in dental implant failure by inhibiting bone growth.

Researchers at the University of Buffalo (UB; NY, USA) performed a retrospective chart review of 74 patients (41 females/33 males) aged 18 or older who received dental implants in the UB post-doctoral dental clinic between January and August 2014. The study cohort consisted of patients who reported using at least one type of antidepressant, while the control group consisted of patients with no such history. The number of implants received per patient ranged between one and 11, with implant failure defined as loss of at least one implant.

The results showed that six (7.9%) of the patients experienced implant failure, each losing only one implant. The frequency of antidepressant use was higher in patients who experienced implant failure (33.3%) compared to those who did not (11.3%). The odds of implant failure among antidepressant drug users were about four times higher compared to controls, with each year of antidepressant use associated with two-fold increase in the odds of implant failure. The study was presented at the 45th annual American Association for Dental Research (AADR) conference, held during March 2016 in Los Angeles (CA, USA).

“Four of the many known side effects that are reported in the literature are a big concern to us as dentists in regard to oral and bone health,” said study coauthor Latifa Bairam, DDS, MS, of the UB department of restorative dentistry. “Additional side effects of antidepressants include osteoporosis; akathisia, a disorder characterized by the need to be in constant motion, including the head and jaw; bruxism, or teeth grinding; and dryness of the mouth, all of which affect the implant healing process.”

Antidepressants are used for the treatment of major depressive disorder and a range of other conditions, including dysthymia, anxiety disorders, obsessive compulsive disorder (OCD), eating disorders, chronic and neuropathic pain and dysmenorrhoea, snoring, migraine, attention deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders.

Related Links:

University of Buffalo



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Enterprise Imaging & Reporting Solution
Syngo Carbon

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more